Clearside Biomedical Q3 EPS $(0.17) Misses $(0.16) Estimate, Sales $141K Beat $10K Estimate

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.16) by 6.25 percent. This is a 77.33 percent increase over losses of $(0.75) per share

Benzinga · 11/06/2019 21:45

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.16) by 6.25 percent. This is a 77.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $141 thousand which beat the analyst consensus estimate of $10 thousand by 1.31K percent.